BiosPacific
BiosPacific is a manufacturer and bulk supplier of monoclonal antibodies, polyclonal antibodies, and purified proteins for in vitro diagnostics (IVD) assay development. Founded in 1989 and based in Emeryville, California, the company serves IVD companies from early-stage startups to multinational diagnostic corporations through a direct B2B sales model.
- Company typePrivate
- Founded1989
- HeadquartersEmeryville, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What BiosPacific does
BiosPacific, Inc. is a privately held manufacturer and supplier of bulk immunological reagents for the commercial in vitro diagnostics (IVD) industry, founded in 1989 and headquartered in Emeryville, California. The company's core products comprise monoclonal antibodies, affinity-purified polyclonal antibodies, native and recombinant proteins, and conjugates (HRP, ALP, BSA, BTG) organized across diagnostic verticals including Cancer, Cardiovascular, Drugs of Abuse, Endocrine/Thyroid, Human Serum Proteins, Neurodegenerative, Infectious Disease, Steroids, and Stripped Serums. Technical differentiation rests on a catalog of thousands of validated antibody-antigen pairs with documented pairing recommendations, supported by an ISO 9001:2015 certified quality management system and 34+ years of IVD-specific domain expertise.
The company operates a direct B2B sales model targeting IVD assay developers from early-stage startups through multinational diagnostic corporations. Go-to-market is conducted through the corporate website, email and phone inquiry handling, printed and digital product catalogs (available in English and Chinese), and active participation in industry events such as ADLM 2026. Pricing is quote-based and not publicly disclosed, reflecting the custom, specification-driven nature of bulk reagent procurement. BiosPacific is a wholly-owned subsidiary of Bio-Techne, a publicly traded diversified life science company, and operates alongside sister brands such as R&D Systems, Novus Biologicals, Bionostics, Cliniqa, Tocris Bioscience, ProteinSimple, and ACD, sharing parent-level resources and technology access.
BiosPacific firmographics
Firmographics- Name
- BiosPacific
- Legal name
- BiosPacific, Inc.
- Website
- https://biospacific.com
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BiosPacific is a manufacturer and bulk supplier of monoclonal antibodies, polyclonal antibodies, and purified proteins for in vitro diagnostics (IVD) assay development. Founded in 1989 and based in Emeryville, California, the company serves IVD companies from early-stage startups to multinational diagnostic corporations through a direct B2B sales model.
- Ownership category
- akta.pro rank
Where BiosPacific is headquartered
LocationHeadquarters
- HQ city
- Emeryville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BiosPacific business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Antibody and Antigen Product Sales: Sale of monoclonal antibodies, polyclonal antibodies, purified proteins, native and recombinant antigens, and conjugates for IVD assay development
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
BiosPacific product offering
Product offeringCore offering
BiosPacific manufactures and supplies bulk monoclonal antibodies, affinity-purified polyclonal antibodies, native and recombinant proteins, and conjugates (HRP, ALP, BSA, BTG) for in vitro diagnostics (IVD) assay development. The portfolio spans cancer, cardiovascular, drugs of abuse, endocrine/thyroid, steroids, neuro, infectious diseases, and human serum protein categories, supporting IVD customers from early-stage feasibility through commercial launch with product pairing recommendations.
Product overview
BiosPacific is a manufacturer and supplier of immunological reagents for the in vitro diagnostics (IVD) industry. The company offers a comprehensive portfolio of monoclonal antibodies, affinity-purified polyclonal antibodies, native and recombinant proteins, and various conjugates (HRP, BSA, ALP, BTG). Products span multiple diagnostic categories including Cancer (AFP, CA-125, CA19-9, CA15-3, PSA, HE4), Cardiovascular (Troponin I, Myoglobin, CK-MB, NT-proBNP, D-dimer), Endocrine/Thyroid (FSH, LH, hCG, Insulin, TSH, T3, T4), Drugs of Abuse (Fentanyl, THC, Methamphetamine, Ketamine), Steroids (Cortisol, Estradiol, Progesterone, Testosterone), Neuro (GFAP, NFL-Ct, p-Tau 217), Infectious Diseases (Influenza, SARS-CoV-2, HAV, HBcAg), and Human Serum Proteins. The company supports customers from early-stage feasibility testing through commercial launch, offering product pairing recommendations for assay development. BiosPacific operates as part of Bio-Techne and is ISO 9001:2015 certified.
Differentiator
Problem solved
Functional benefit
Products and services
- Cancer Monoclonal Antibodies Murine-derived monoclonal antibodies designed and developed for the commercial in vitro diagnostics market, supporting cancer diagnosis, prognosis, and monitoring across markers including AFP, CA-125, CA19-9, CA15-3, PSA, and HE4.
- Purified Proteins and Antigens Native and recombinant proteins used for development of controls, calibrators, and linearity material in diagnostic assays.
- Cardiovascular Antibodies and Antigens Antibodies targeting cardiac markers including Troponin I, Myoglobin, CK-MB, NT-proBNP, D-dimer, MPO, and FABP for cardiovascular diagnostics.
- Drugs of Abuse and Therapeutic Drug Antibodies Antibodies and conjugates for drugs of abuse testing including Fentanyl, K2, Gabapentin, Ketamine, LSD, Methamphetamine, THC, UR-144, Xylazine, and therapeutic drug monitoring.
- Endocrine and Thyroid Antibodies and Antigens Antibodies and antigens for endocrine and thyroid markers including FSH, LH, hCG, hGH, Insulin, IGF-1, TSH, T3, T4, and Thyroglobulin.
- Steroid Antibodies Antibodies and conjugates for steroid hormones including Cortisol, Estradiol, Progesterone, and Testosterone for diagnostic platforms.
- Neuro Antibodies and Antigens Antibodies targeting neurological biomarkers including GFAP, IL-6, IFN-gamma, NFL-Ct, NSE, p-Tau 217, S100BB, and TNF-alpha for neurodegenerative disease diagnostics.
- Infectious Disease Antibodies and Antigens Antibodies and antigens for infectious disease diagnostics including Adenovirus, Chlamydia, CMV, Influenza A, Influenza B, HAV, HBcAg, and SARS-CoV-2.
- Human Serum Protein Antibodies and Antigens Antibodies targeting serum proteins including Albumin, Alpha-1 Antitrypsin, Apolipoprotein E, CRP, Hemoglobin, Transferrin, and immunoglobulins (IgA, IgG, IgM).
- Antibody and Antigen Conjugates Enzyme conjugates including HRP (horseradish peroxidase), ALP (alkaline phosphatase), BSA conjugates, and BTG conjugates for assay development.
Companies that use BiosPacific
Customer profileSegments3 records
Ideal customer profiles3 records
BiosPacific technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
BiosPacific partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Bio-TechnecoreBiosPacific is a brand within the Bio-Techne portfolio of life science and diagnostic companies. As part of Bio-Techne, BiosPacific has access to cutting-edge biomarker discovery technology and shares resources with sister brands including R&D Systems, Novus Biologicals, Cliniqa, Bionostics, and others.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
BiosPacific competitors and assessment
Company assessmentBroad incumbents
- Abcam (Danaher): Abcam, now part of Danaher, supplies a broad catalog of antibodies and reagents primarily to research and diagnostics customers. While more research-focused than BiosPacific, it competes for IVD-grade reagent share and offers adjacent pairing/validation services.
- Bio-Rad Laboratories: Bio-Rad is a major life sciences and diagnostics incumbent offering an extensive catalog of antibodies, antigens, controls, and IVD reagents. While broader in scope than BiosPacific, it competes directly in supplying immunological reagents to IVD assay developers.
- Merck KGaA (Millipore Sigma Life Science): Millipore Sigma supplies an extensive catalog of research- and diagnostic-grade antibodies and proteins to biopharma, academic, and IVD customers. It is a broad incumbent competitor in the antibody/antigen market, including for IVD assay development.
Direct peers
- Aalto Scientific: Aalto Scientific manufactures diagnostic reagents, calibrators, and controls for IVD manufacturers, with a comparable focus on bulk reagents and immunoassay components for clinical diagnostics.
- Surmodics: Surmodics' Diagnostics division provides IVD reagents and antibody/antigen offerings to diagnostic manufacturers. It is a direct competitor in the supply of immunoassay components for clinical diagnostic platforms.
- BBI Solutions: BBI Solutions manufactures IVD-grade antibodies, antigens, and lateral-flow reagents for diagnostic manufacturers. It operates in the same niche as BiosPacific, supplying bulk immunological reagents to IVD assay developers across multiple disease areas.
- EKF Diagnostics: EKF Diagnostics develops and supplies reagents and diagnostic test kits, including immunoassay components for clinical and point-of-care applications. It overlaps with BiosPacific in supplying IVD manufacturers and clinical labs.
- Medix Biochemica (incl. Fitzgerald Industries): Medix Biochemica is a direct competitor supplying monoclonal antibodies and antigens specifically for the IVD industry, including through its acquisition of Fitzgerald Industries. Like BiosPacific, it focuses on diagnostic-grade reagents serving immunoassay developers globally.
- Hytest (Aidian): Hytest is a Finnish specialist in monoclonal antibodies and antigens for IVD manufacturers, particularly strong in cardiac markers (Troponin) and infectious disease. It is now part of Aidian (formerly part of QuidelOrtho) and competes head-to-head with BiosPacific in IVD reagent supply.
Emerging players
- ACROBiosystems: ACROBiosystems is a rapidly growing recombinant protein and reagent supplier with an expanding IVD reagent catalog. It represents an emerging competitor in the bulk antibody/antigen space, particularly in recombinant antigens.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
BiosPacific social profiles
Digital presenceBiosPacific compliance and trust
Trust signalCompliance1 record
BiosPacific financial estimates
Financial estimateRevenue estimate
Valuation estimate
BiosPacific leadership team
Management profileNumber of profiles
BiosPacific funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BiosPacific M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BiosPacific
What does BiosPacific do?
BiosPacific manufactures and supplies bulk monoclonal antibodies, affinity-purified polyclonal antibodies, native and recombinant proteins, and conjugates (HRP, ALP, BSA, BTG) for in vitro diagnostics (IVD) assay development. The portfolio spans cancer, cardiovascular, drugs of abuse, endocrine/thyroid, steroids, neuro, infectious diseases, and human serum protein categories, supporting IVD customers from early-stage feasibility through commercial launch with product pairing recommendations.
Is BiosPacific a public or private company?
BiosPacific is a private company. It is classified as corporate owned and is currently operating.
When was BiosPacific founded?
BiosPacific was founded in 1989. It employs 1 to 10 people.
Where is BiosPacific based?
BiosPacific is headquartered in Emeryville, United States, in the North America region.
How does BiosPacific make money?
One revenue line is on record: antibody and Antigen Product Sales.
Who are BiosPacific's main competitors?
Broad incumbents on record are Abcam (Danaher), Bio-Rad Laboratories and Merck KGaA (Millipore Sigma Life Science). Direct peers are Aalto Scientific, Surmodics, BBI Solutions, EKF Diagnostics, Medix Biochemica (incl. Fitzgerald Industries) and Hytest (Aidian). ACROBiosystems is listed as an emerging player.
Does BiosPacific have an API?
No public API is recorded for BiosPacific.